The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson's Disease: An Updated Systematic Review.
Vikash JaiswalDanah AlquraishZouina SarfrazPiero SchiròShavy NagpalPrakriti Singh ShresthaDattatreya MukherjeePrathima GuntipalliDiana Fiorela Sánchez VelazcoArushee BhatnagarSaloni SavaniElmjedina HalilajSamir RuxmohanWilson CuevaPublished in: Journal of primary care & community health (2021)
Patients with PD may experience substantial worsening of symptoms due to COVID 19. Given the novelty of neurological-viral associations, clinical studies in the future ought to explore the disease severity and neurological outcomes in COVID-19 positive patients with PD as compared to non-PD patients, in addition to understanding the role of ACE2 in increased vulnerability to contracting the infection and as a treatment modality.
Keyphrases
- coronavirus disease
- sars cov
- systematic review
- respiratory syndrome coronavirus
- end stage renal disease
- ejection fraction
- newly diagnosed
- meta analyses
- prognostic factors
- peritoneal dialysis
- type diabetes
- current status
- physical activity
- angiotensin ii
- metabolic syndrome
- patient reported outcomes
- adipose tissue
- insulin resistance
- angiotensin converting enzyme
- smoking cessation